
Granules India Ltd. — Investor Relations & Filings
Granules India Ltd. is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). The organization maintains a significant global presence through the large-scale production of essential molecules, including Paracetamol, Ibuprofen, Metformin, Methocarbamol, and Guaifenesin. Its business model emphasizes a complete value chain approach, from core chemical synthesis to final product packaging, ensuring operational efficiency and supply chain security. The company serves a diverse international clientele across more than 75 countries, utilizing advanced manufacturing facilities that comply with global regulatory standards. Key strengths include high-volume production capabilities, cost leadership, and a focus on delivering consistent quality in high-demand therapeutic areas.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Spurt in Volume | 2026-05-28 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-05 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-29 | English | |
| Outcome of Board Meeting | 2026-04-29 | English | |
| Record Date | 2026-04-29 | English | |
| Monitoring Agency Report | 2026-04-29 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47853202 | Spurt in Volume | 2026-05-28 | English | ||
| 42190443 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-05 | English | ||
| 42184001 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-29 | English | ||
| 42189199 | Outcome of Board Meeting | 2026-04-29 | English | ||
| 42191621 | Record Date | 2026-04-29 | English | ||
| 42191643 | Monitoring Agency Report | 2026-04-29 | English | ||
| 42193237 | Press Release | 2026-04-29 | English | ||
| 42193327 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-29 | English | ||
| 42193495 | Change in Management | 2026-04-29 | English | ||
| 42193565 | Outcome of Board Meeting | 2026-04-29 | English | ||
| 42193812 | Outcome of Board Meeting | 2026-04-29 | English | ||
| 42168879 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-16 | English | ||
| 43865664 | Board Meeting — Board Meeting Intimation | 2026-04-16 | English | ||
| 43865676 | Board Meeting — Financial Results/Dividend | 2026-04-16 | English | ||
| 42216151 | Press Release | 2026-04-04 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
|
Aprogen Biologics Inc.
Develops and manufactures novel biologics and biosimilar an…
|
003060 | KR | Manufacturing |
|
Aprogen, Inc
Develops and manufactures biologic medicines, including bio…
|
007460 | KR | Manufacturing |
|
Aptabio Therapeutics Inc.
Develops drugs for intractable diseases by regulating oxida…
|
293780 | KR | Manufacturing |
|
Aptamer Sciences Inc
Clinical-stage company developing aptamer-based therapeutic…
|
291650 | KR | Manufacturing |
|
Aptorum Group Ltd
Clinical-stage biopharma developing therapeutics for oncolo…
|
APM | US | Manufacturing |
|
Aptus Pharma Limited
Develops and manufactures cardiovascular, metabolic, and ga…
|
544529 | IN | Manufacturing |
Granules India Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60224/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60224 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60224 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60224 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60224}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Granules India Ltd. (id: 60224)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.